Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]lu-Psma-617 in the Phase 3 VISION Trial

Andrew J. Armstrong,Oliver Sartor,Johann de Bono,Kim Chi,Karim Fizazi,Bernd J. Krause,Ken Herrmann,Kambiz Rahbar,Scott T. Tagawa,Fred Saad,Tomasz M. Beer,Jiwen Wu,Osvaldo Mirante,Michael J. Morris

European Urology（2024）

引用 0|浏览7

暂无评分

关键词

177Lu-PSMA-617,Metastatic castration-resistant prostate cancer,Prognostic biomarker,Prostate-specific antigen,Radioligand therapy,Randomised controlled trial

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要